Product image of Noprilam 125 (Amoxicillin, Clavulanic Acid) supplied by GNH India

Noprilam 125

Active Ingredient:
Amoxicillin, Clavulanic Acid
Origin:
EU

Noprilam 125 (Amoxicillin, Clavulanic Acid)

Amoxicillin, the active ingredient in Noprilam 125, is a Penicillin beta‑lactamase inhibitor combination presented as an oral tablet for systemic use. It treats bacterial infections of the respiratory tract, ears, urinary system, skin and related tissues in adults and children as prescribed.

GNH India supplies Noprilam 125 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bial - Portela & Cª , Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Noprilam 125, containing amoxicillin/clavulanic acid, is indicated for bacterial infections affecting several organ systems.

  • Respiratory tract infections: reduces bacterial load and alleviates cough, fever and sputum production.
  • Sinusitis: clears sinus inflammation caused by susceptible bacteria.
  • Otitis media: treats middle‑ear infections and prevents complications.
  • Urinary tract infections: eradicates common uropathogens and resolves dysuria.
  • Skin and soft tissue infections: combats cellulitis and wound infections caused by susceptible strains.

How It Works

  • Amoxicillin binds to penicillin‑binding proteins, blocking the final transpeptidation step of bacterial cell‑wall synthesis, which leads to cell lysis. Clavulanic acid, a β‑lactamase inhibitor, irreversibly binds to β‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin from enzymatic degradation and extending its antibacterial spectrum.

Side Effects

Adverse reactions to Noprilam 125 vary in frequency and severity.

Common Side Effects

  • Diarrhea: mild to moderate loose stools.
  • Nausea: feeling of stomach discomfort.
  • Vomiting: occasional emesis.
  • Rash: mild skin erythema or itching.
  • Headache: transient cranial pain.

Serious or Rare Side Effects

  • Anaphylaxis: severe, potentially life‑threatening allergic reaction.
  • Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder.
  • Clostridioides difficile‑associated diarrhea: severe colitis after antibiotic use.
  • Hepatic enzyme elevation: significant increase in liver transaminases.
  • Neutropenia: marked reduction in neutrophil count.
  • Seizures: rare central nervous system excitation, especially in renal impairment.

Precautions & Warnings

When prescribing Noprilam 125, clinicians should consider several precautionary measures.

  • Allergy assessment: verify no known hypersensitivity to penicillins or β‑lactamase inhibitors.
  • Renal function: adjust dose in patients with impaired kidney function.
  • Hepatic function: monitor liver enzymes in patients with liver disease.
  • Pregnancy and lactation: use only if clearly needed, as safety data are limited.
  • Elderly patients: start with lower dose and monitor for adverse effects.
  • Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Noprilam 125 may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Probenecid: decreases renal excretion of amoxicillin, increasing plasma levels.
  • Oral contraceptives: may reduce hormonal efficacy, increasing risk of unintended pregnancy.
  • Warfarin: potentiates anticoagulant effect, raising INR and bleeding risk.

Moderate Interactions (Monitor Closely)

  • Aminoglycosides: concurrent use may increase risk of nephrotoxicity.
  • Tetracyclines: may antagonize antibacterial activity, reducing therapeutic effect.

Frequently Asked Questions

Noprilam 125 contains amoxicillin and clavulanic acid and is prescribed for bacterial infections such as community‑acquired respiratory tract infections, acute sinusitis, otitis media, uncomplicated urinary tract infections, and skin or soft‑tissue infections caused by susceptible organisms.

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, while clavulanic acid blocks β‑lactamase enzymes that some bacteria produce to inactivate amoxicillin. This combination expands the spectrum of activity and helps eradicate resistant strains.

The dosage of Noprilam 125 is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, renal function and other clinical factors. Only a qualified health professional should set the regimen.

Safety data for amoxicillin/clavulanic acid in pregnancy are limited, and the product is classified as a pregnancy category unknown. It should be used only if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult a physician before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Plain amoxicillin lacks the β‑lactamase inhibitor component, so some bacteria that produce β‑lactamases can inactivate it. Noprilam 125 adds clavulanic acid, which protects amoxicillin from degradation, giving a broader spectrum of activity against β‑lactamase‑producing organisms.

Noprilam 125 tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture, heat and direct sunlight. Do not store in a bathroom or near a kitchen sink where humidity is high.

Noprilam 125 is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can reduce gastrointestinal upset. The exact timing and frequency are set by the prescribing clinician.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, hepatic enzyme elevation, neutropenia and, in rare cases, seizures. Patients should seek immediate medical attention if they experience rash, difficulty breathing, persistent diarrhea or jaundice.

Individuals with a known hypersensitivity to amoxicillin, other penicillins, clavulanic acid, or any component of the formulation should avoid Noprilam 125. It is also contraindicated in patients with a history of cholestatic jaundice or hepatic dysfunction linked to amoxicillin/clavulanic acid.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Amoxicillin, Clavulanic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT